News
The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...
A major new study has shown that a group of drugs called GLP-1 receptor agonists offer strong protection for both the kidneys ...
A YOUNG woman has revealed that in 14 weeks, she has lost three stone on Mounjaro. But although Jess now feels “healthier” ...
Meshel Laurie has got candid about her whopping 60kg weight loss as she called for a controversial obesity medication to be added to the Pharmaceutical Benefits Scheme (PBS).
We are nearing a point of no return for GLP-1 drugs. More than one in 10 Americans have already taken a GLP-1 agonist, be it ...
Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...
Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.
GLP-1s (glucagon-like peptide-1 receptor agonists), like Wegovy, Ozempic, or generic liraglutide, have helped you reach your ...
A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...
The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.
New research has revealed that people taking weight loss drugs like Wegovy and Mounjaro are increasingly more likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results